CAPRICOR THERAPEUTICS, INC. Contract Liability (Deferred Revenue)
CAPRICOR THERAPEUTICS, INC. (CAPR) had Contract Liability (Deferred Revenue) of $12.00 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Contract with Customer, Liability, Current $12.00M.
- 2026-03-31: Contract with Customer, Liability, Current $12.00M.
- 2025-12-31: Contract with Customer, Liability, Current $12.00M.
- 2025-09-30: Contract with Customer, Liability, Current $12.00M.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $12.00M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $12.00M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $12.00M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $12.00M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $12.00M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $12.00M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $12.00M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $13.13M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $15.39M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $19.36M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $24.27M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $25.41M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $29.31M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $31.01M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $17.98M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $18.56M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $15.75M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $30.00M 10-K · filed 2023-03-17 | $9.73M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |